In Brief: Insurance coverage for clinical trials
Executive Summary
Insurance coverage for clinical trials: HR 3958 introduced by Rep. Johnson (R-Conn.) Aug. 2 to ensure coverage under federal health care programs for patients enrolled in clinical trials. The bill would also establish a government database to "make available to the public information about clinical investigations and results obtained from approved clinical studies." HR 3959, introduced by Johnson the same day, would establish a demonstration project limited to Medicare coverage of cancer patients in clinical trials. Johnson stressed that the bills would ensure coverage of "routine medical costs associated with the patient's treatment," but not the investigational agent itself...
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth